skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover assunto: Science & Technology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer
Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer

MORRIS, Luc G. T ; SIKORA, Andrew G ; PATEL, Snehal G ; HAYES, Richard B ; GANLY, Ian

Journal of clinical oncology, 2011-02, Vol.29 (6), p.739-746 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements

MCLAUGHLIN, Sarah A ; WRIGHT, Mary J ; MORRIS, Katherine T ; GIRON, Gladys L ; SAMPSON, Michelle R ; BROCKWAY, Julia P ; HURLEY, Karen E ; RIEDEL, Elyn R ; VAN ZEE, Kimberly J

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5213-5219 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors

MCLAUGHLIN, Sarah A ; WRIGHT, Mary J ; MORRIS, Katherine T ; SAMPSON, Michelle R ; BROCKWAY, Julia P ; HURLEY, Karen E ; RIEDEL, Elyn R ; VAN ZEE, Kimberly J

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5220-5226 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

DE GEEST, Koen ; BLESSING, John A ; MORRIS, Robert T ; DIANE YAMADA, S ; MONK, Bradley J ; ZWEIZIG, Susan L ; MATEI, Daniela ; MULLER, Carolyn Y ; RICHARDS, William E

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study

Copeland, Larry J ; Brady, Mark F ; Burger, Robert A ; Rodgers, William H ; Huang, Helen Q ; Cella, David ; O'Malley, David M ; Street, Daron G ; Tewari, Krishnansu S ; Bender, David P ; Morris, Robert T ; Lowery, William J ; Miller, David S ; Dewdney, Summer B ; Spirtos, Nick M ; Lele, Shashikant B ; Guntupalli, Saketh ; Ueland, Frederick R ; Glaser, Gretchen E ; Mannel, Robert S ; DiSaia, Philip J

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4119-4128 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
6
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)

Ho, Alan L ; Foster, Nathan R ; Zoroufy, Alex J ; Campbell, Jordan D ; Worden, Francis ; Price, Katharine ; Adkins, Douglas ; Bowles, Daniel W ; Kang, Hyunseok ; Burtness, Barbara ; Sherman, Eric ; Morton, Roscoe ; Morris, Luc G T ; Nadeem, Zaineb ; Katabi, Nora ; Munster, Pamela ; Schwartz, Gary K

Journal of clinical oncology, 2022-12, Vol.40 (36), p.4240-4249 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
7
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Chi, Kim N ; Rathkopf, Dana ; Smith, Matthew R ; Efstathiou, Eleni ; Attard, Gerhardt ; Olmos, David ; Lee, Ji Youl ; Small, Eric J ; Pereira de Santana Gomes, Andrea J ; Roubaud, Guilhem ; Saad, Marniza ; Zurawski, Bogdan ; Sakalo, Valerii ; Mason, Gary E ; Francis, Peter ; Wang, George ; Wu, Daphne ; Diorio, Brooke ; Lopez-Gitlitz, Angela ; Sandhu, Shahneen

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3339-3351, Article 3339 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
8
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

Korde, Larissa A ; Somerfield, Mark R ; Carey, Lisa A ; Crews, Jennie R ; Denduluri, Neelima ; Hwang, E Shelley ; Khan, Seema A ; Loibl, Sibylle ; Morris, Elizabeth A ; Perez, Alejandra ; Regan, Meredith M ; Spears, Patricia A ; Sudheendra, Preeti K ; Symmans, W Fraser ; Yung, Rachel L ; Harvey, Brittany E ; Hershman, Dawn L

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1485-1505 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
9
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Baxter, Nancy N ; Kennedy, Erin B ; Bergsland, Emily ; Berlin, Jordan ; George, Thomas J ; Gill, Sharlene ; Gold, Philip J ; Hantel, Alex ; Jones, Lee ; Lieu, Christopher ; Mahmoud, Najjia ; Morris, Arden M ; Ruiz-Garcia, Erika ; You, Y Nancy ; Meyerhardt, Jeffrey A

Journal of clinical oncology, 2022-03, Vol.40 (8), p.892-910 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

BASHEY, Asad ; XU ZHANG ; SIZEMORE, Connie A ; MANION, Karen ; BROWN, Stacey ; HOLLAND, H. Kent ; MORRIS, Lawrence E ; SOLOMON, Scott R

Journal of clinical oncology, 2013-04, Vol.31 (10), p.1310-1316 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2010  (22)
  2. 2010Até2012  (32)
  3. 2013Até2015  (21)
  4. 2016Até2019  (12)
  5. Após 2019  (22)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.